Article: All oral, fixed-duration ibrutinib + venetoclax leads to long treatment-free remissions in patients with previously untreated CLL/SLL

3.03

SKU: product-article-44225 Category:

Description

All oral, fixed-duration ibrutinib + venetoclax leads to long treatment-free remissions in patients with previously untreated CLL/SLL

Reviews

There are no reviews yet.

Be the first to review “Article: All oral, fixed-duration ibrutinib + venetoclax leads to long treatment-free remissions in patients with previously untreated CLL/SLL”